Experts share their experience with oral hypomethylating agents in myelodysplastic syndrome and consider how else these agents might be used moving forward. Bart Scott, MD, MS: Access to care is a big ...
Experts discuss the impact of supportive care in the MDS treatment landscape. Ryan Haumschild, PharmD, MS, MBA: Dr Zeidan, from your perspective, what are some of the supportive care needs for ...
CURE interviewed Thomas Prebet to gain insight into the importance of supportive care in myelodysplastic syndrome. The proper administration of supportive care can have a significant impact on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results